BINOCRIT Trademark

Trademark Overview

On Friday, May 21, 2010, a trademark application was filed for BINOCRIT with the United States Patent and Trademark Office. The USPTO has given the BINOCRIT trademark a serial number of 85044687. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2014. This trademark is owned by Novartis AG. The BINOCRIT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, the immune system and the cardiovascular system and for use in oncology; pharmaceutical preparations for the treatment of blood and blood forming organs
binocrit

General Information

Serial Number85044687
Word MarkBINOCRIT
Filing DateFriday, May 21, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 12, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, the immune system and the cardiovascular system and for use in oncology; pharmaceutical preparations for the treatment of blood and blood forming organs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 26, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, January 13, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 13, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 4, 2013EXTENSION 5 GRANTED
Monday, June 3, 2013EXTENSION 5 FILED
Monday, June 3, 2013TEAS EXTENSION RECEIVED
Saturday, December 8, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 7, 2012EXTENSION 4 GRANTED
Wednesday, December 5, 2012EXTENSION 4 FILED
Wednesday, December 5, 2012TEAS EXTENSION RECEIVED
Saturday, June 9, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 8, 2012EXTENSION 3 GRANTED
Wednesday, June 6, 2012EXTENSION 3 FILED
Wednesday, June 6, 2012TEAS EXTENSION RECEIVED
Wednesday, December 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 13, 2011EXTENSION 2 GRANTED
Monday, December 5, 2011EXTENSION 2 FILED
Tuesday, December 13, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 5, 2011TEAS EXTENSION RECEIVED
Wednesday, June 8, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 6, 2011EXTENSION 1 GRANTED
Monday, June 6, 2011EXTENSION 1 FILED
Monday, June 6, 2011TEAS EXTENSION RECEIVED
Tuesday, December 7, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 12, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 12, 2010PUBLISHED FOR OPPOSITION
Thursday, September 9, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 9, 2010ASSIGNED TO LIE
Thursday, August 26, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 25, 2010ASSIGNED TO EXAMINER
Wednesday, May 26, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 25, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

binocrit system blood treatment preparations pharmaceutical oncology forming organs cardiovascular nervous